2,336 Shares in Elevance Health, Inc. $ELV Acquired by Diversify Advisory Services LLC

Diversify Advisory Services LLC bought a new position in Elevance Health, Inc. (NYSE:ELV) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,336 shares of the company’s stock, valued at approximately $876,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ELV. Sei Investments Co. grew its holdings in Elevance Health by 7.7% during the 2nd quarter. Sei Investments Co. now owns 163,668 shares of the company’s stock valued at $63,666,000 after buying an additional 11,745 shares in the last quarter. Glenview Trust co grew its holdings in Elevance Health by 41.5% during the 2nd quarter. Glenview Trust co now owns 1,619 shares of the company’s stock valued at $630,000 after buying an additional 475 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its holdings in Elevance Health by 6.9% during the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 65,945 shares of the company’s stock valued at $25,650,000 after buying an additional 4,272 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Elevance Health by 5.0% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 42,371 shares of the company’s stock valued at $16,478,000 after buying an additional 2,012 shares in the last quarter. Finally, Quantinno Capital Management LP grew its holdings in Elevance Health by 111.8% during the 2nd quarter. Quantinno Capital Management LP now owns 43,911 shares of the company’s stock valued at $17,080,000 after buying an additional 23,180 shares in the last quarter. 89.24% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ELV shares. Evercore started coverage on shares of Elevance Health in a report on Wednesday, April 8th. They set a “hold” rating and a $345.00 price objective for the company. UBS Group set a $400.00 price objective on shares of Elevance Health in a report on Thursday, January 29th. Mizuho cut their price objective on shares of Elevance Health from $413.00 to $350.00 and set an “outperform” rating for the company in a report on Wednesday, March 11th. Morgan Stanley lowered their target price on Elevance Health from $359.00 to $352.00 and set an “equal weight” rating for the company in a research report on Wednesday, December 17th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $332.00 target price on shares of Elevance Health in a research report on Thursday, January 29th. Twelve investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $384.67.

Elevance Health Stock Up 1.5%

NYSE:ELV opened at $316.07 on Tuesday. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $443.29. The company has a market cap of $69.43 billion, a price-to-earnings ratio of 12.58, a price-to-earnings-growth ratio of 1.71 and a beta of 0.49. The stock has a fifty day simple moving average of $310.73 and a 200-day simple moving average of $332.12. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.70.

Elevance Health (NYSE:ELV) last released its earnings results on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, topping the consensus estimate of $3.10 by $0.23. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The business had revenue of $49.31 billion during the quarter, compared to the consensus estimate of $49.52 billion. During the same period last year, the company earned $3.84 earnings per share. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Analysts anticipate that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th were given a dividend of $1.72 per share. This represents a $6.88 annualized dividend and a dividend yield of 2.2%. This is a positive change from Elevance Health’s previous quarterly dividend of $1.71. The ex-dividend date was Tuesday, March 10th. Elevance Health’s dividend payout ratio is 27.39%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.